Drug recall · April 5, 2023
Simvastatin recall
Why: cGMP deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Simvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0710-90 Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534
- Lots / codes
Lot, expiry: 03JA2209, 28FE2225, 28AP2211, 07AP2203, exp 6/30/23
- Quantity
- 51 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- Nationwide in the USA
- Initiated
- March 13, 2023 · Voluntary: Firm initiated
- Classified
- March 24, 2023
- Reported
- April 5, 2023
- Ended
- June 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Simvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.